Page last updated: 2024-09-03

kb 5492 and Gastric Ulcer

kb 5492 has been researched along with Gastric Ulcer in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hara, H; Harada, Y; Sukamoto, T; Tanaka, K1
Morimoto, Y; Oshima, S; Shimohara, K; Sukamoto, T1
Niida, H; Okabe, S; Shimohara, K1

Other Studies

3 other study(ies) available for kb 5492 and Gastric Ulcer

ArticleYear
Sigma receptor-mediated effects of a new antiulcer agent, KB-5492, on experimental gastric mucosal lesions and gastric alkaline secretion in rats.
    The Journal of pharmacology and experimental therapeutics, 1994, Volume: 269, Issue:2

    Topics: Animals; Anti-Ulcer Agents; Autoradiography; Carbazoles; Ethanol; Gastric Mucosa; Guanidines; Haloperidol; Hydrogen-Ion Concentration; In Vitro Techniques; Male; Piperazines; Rats; Rats, Sprague-Dawley; Receptors, sigma; Stomach Ulcer; Stress, Physiological

1994
Effects of the new anti-ulcer agent KB-5492 on experimental gastric mucosal lesions and gastric mucosal defensive factors, as compared to those of teprenone and cimetidine.
    Japanese journal of pharmacology, 1991, Volume: 57, Issue:4

    Topics: Administration, Oral; Animals; Anti-Ulcer Agents; Cimetidine; Diterpenes; Gastric Acid; Gastric Mucosa; Hexosamines; Male; Piperazines; Rats; Rats, Inbred Strains; Stomach Ulcer

1991
Effects of KB-5492, 1-(3,4,5-trimethoxybenzyl)-4-((4-methoxyphenyl)oxycarbonylmethyl) p iperazine monofumarate monohydrate, on gastric lesions and gastric secretion in rats.
    Japanese journal of pharmacology, 1990, Volume: 53, Issue:2

    Topics: Animals; Anti-Ulcer Agents; Chalcone; Chalcones; Gastric Mucosa; Immersion; Male; Piperazines; Rats; Rats, Inbred Strains; Stomach Ulcer; Stress, Physiological

1990